|
|
|
Market Research Report
Biopharmaceuticals in South East Asia
|
Biopharmaceuticals in South East Asia published by Espicom Business Intelligence in July, 2008. This report consists of Pages: 204 and the price starts from US $ 1390.
Abstract
Often overshadowed by commercial interest in China and India, the countries of
SE Asia offer both a growing market for biopharmaceuticals and a
research-driven environment for their development.
The worldwide market for biotechnology pharmaceuticals was valued by Espicom
at an estimated US$80 billion in 2007, representing 9.6% of the total global
pharmaceutical sales (prescription and OTC), which stood at approximately
US$830 billion. In 2007, reported sales of 40 of the leading
biopharmaceuticals sold by the major western manufacturers totalled US$71.6
billion, having risen by 13.7% over the previous year.
This detailed report analyses the market and research environments, assessing
risk and identifying opportunity in Indonesia, Malaysia, Singapore, South
Korea, Taiwan and Thailand.
Providing......
- A thorough review of the burgeoning market for biopharmaceutical drugs in
SE Asia
- An examination of the markets in terms of investment and research
opportunities
- Market forecasts to 2013 for biopharmaceuticals
- A review of over 65 local companies/ organisations developing
biopharmaceutical products
Markets covered......
- Indonesia
- Malaysia
- Singapore
- South Korea
- Taiwan
- Thailand
Table of Contents
- FOREWORD
- OVERVIEW
- The Global Market for Biotechnology Pharmaceuticals
- Biotechnology Pharmaceuticals in the Global Market, 2007
- Leading Biopharmaceuticals by Revenue, 2007 (US$ million)
- Leading Biopharmaceuticals Ranked by US$ Revenue Growth, 2006/2007
million)
- Global Pharmaceutical Sales by Region, 2008
- Estimated Global Biopharmaceutical Sales by Region, 2008
- Estimated South East Asian Biopharmaceutical Sales, 2008
- Estimated South East Asian Biopharmaceutical Sales, 2008
- Projected South East Asian Biopharmaceutical Sales, 2008-2013
- Case Study: India" s Biopharmaceutical Market, 2002
- South East Asia - Pharmaceutical Market Data
- South East Asian Pharmaceutical Market, 2008-13 (US$ Millions)
- South East Asian Pharmaceutical Market Per Capita, 2008-13 (US$)*
- South East Asian Pharmaceutical Market AAGR, 2008-13 (%)
- South East Asia - Demographic Data
- South East Asian Population*, 2008-13 (Millions)
- South East Asian Population Growth*, 2008-13 (%)
- South East Asian Population*, Number Aged 65+, 2008-13 (Millions)
- South East Asian Population*, % Aged 65+, 2008-13
- South East Asia - Economic Data
- South East Asian GDP*, 2008-13 (US$ Billions)
- South East Asian GDP Per Capita*, 2008-13 (US$)
- South East Asian Real GDP Growth*, 2008-13 (%)
- South East Asia - Healthcare Expenditure
- South East Asian Health Expenditure*, 2008-13 (US$ Billions)
- South East Asian Health Expenditure Per Capita*, 2008-13 (US$)
- South East Asian Health Expenditure as % of GDP*, 2008-13
- South East Asia - Pharmaceutical Trade
- South East Asian Pharmaceutical Imports, 2001-06 (US$000s)
- South East Asian Pharmaceutical Exports, 2001-06 (US$000s)
- BIOTECHNOLOGY IN SOUTH EAST ASIA
- Selection of Biotechnology as a Key Strategic Area
- BIOPHARMACEUTICALS IN SOUTH EAST ASIA
- Biosimilars
- Rapidly growing markets
- Significant untapped demand
- Less competition from originators
- Greater acceptance from users
- Regulatory barriers are likely to be lower
- INDONESIA
- Biopharmaceutical Market
- Indonesia - Projected Biopharmaceutical Market 2008-2013 (US$ million)
- Pharmaceutical Market
- Summary of the Indonesian Pharmaceutical Market in 2008
- Projected Pharmaceutical Market, 2008-2013
- Market Environment
- Government Biotechnology Initiatives
- Biopharmaceutical Research Agencies
- Indonesian Institute of Sciences (Lembaga Ilmu Pengetahuan
Indonesia - LIPI)
- Indonesian Biotechnology Consortium
- Galang Island
- Biopharmaceutical Manufacturing
- PT Bio Farma
- Kalbe Farma Biotek
- Kimia Farma
- Agreements
- LIPI
- Fraunhofer Institute
- Financials
- KOREA
- Biotechnology Market
- Korean Biotechnology Market 1994-2005
- Government Biotechnology Initiatives
- Korean Government Investment in Biotechnology R&D 1994-2006 (KRW
billion)
- Korea" s 2007-2016 Biotechnology Development Strategy
- Korea" s 2006-2015 Biotechnology Development Strategy Targets (US$
billion)
- Investment
- Planned Investment in Korean Biotechnology 2007-2016
- Employment
- Biopharmaceutical Market
- Korea - Projected Biopharmaceutical Market 2008-2013 (US$ million)
- Pharmaceutical Market
- Summary of the Korean Pharmaceutical Market in 2008
- Projected Pharmaceutical Market, 2008-2013
- Market Environment
- Manufacturing & Research
- Bukwang Pharma
- Financials
- Bukwang Pharmaceutical - Key Financial Data 2004-2006* (KRW
billion)
- Chemizon
- Agreements
- Korean Research Institute of Bioscience and Biotechnology (KRIBB)
- Crown Bioscience
- Takeda
- Array BioPharma
- Chong Kun Dang Bio
- Choongwae Pharma
- CJ CheilJedang
- Daewoong Pharma
- Research
- Daewoong Pharma - Biopharmaceutical Pipeline
- Financials
- Daewoong Pharma - Key Financial Data 2005-2007* (KRW billion)
- Dong-A Pharma
- Biopharmaceutical Product Portfolio
- Dong-A Pharmaceutical - Biopharmaceutical Product Portfolio
- Dong-A Pharmaceutical Export Plan for Biopharmaceuticals
- Research
- Dong-A Pharmaceutical - R&D Pipeline
- DA-3031
- HB-110
- 2008 Plans
- Agreements
- Financials
- Dong-A Pharmaceutical - Key Financial Data 2005-2007* (KRW billion)
- Dong-A Pharmaceutical - % of Revenues by Region, 2007 & 2012*
- Dong-A Pharmaceutical - Biopharmaceutical Revenues, 2007* (KRW
billion)
- Green Cross
- Product Portfolio
- Blood Derivatives
- Vaccines
- R&D Pipeline
- Green Cross - R&D Pipeline
- Mogam Biotechnology Research Institute
- Korea Stem Cell Bank
- Kuhnil Pharmaceutical Company
- Agreements
- LG Life Sciences
- LG Life Sciences - Product Portfolio
- Financial Overview
- LG Life Sciences - Key Financial Data 2004-2006 (billion won)
- LG Life Sciences - Revenue by Segment, 2006
- Sewon Cellontech
- SK Chemicals Life Science
- Yuhan Pharmaceuticals
- MALAYSIA
- Biopharmaceutical Market
- Malaysia - Projected Biopharmaceutical Market 2008-2013 (US$ million)
- Pharmaceutical Market
- Summary of the Malaysian Pharmaceutical Market in 2008
- Projected Pharmaceutical Market, 2008-2013
- Market Environment
- Government Biotechnology Initiatives
- Phase I - 2006-2010 "Capacity Building"
- Phase II - 2011-2015 "Science to Business"
- Phase III - 2016-2020 "Global Presence"
- NBP Focus Areas
- Creation of BioNexus
- Tax Incentives
- Eighth National Plan 2001-2005
- Human Resource Development
- Research and Development
- Infrastructure and Facilities
- Regulatory Framework
- Public R&D Biotechnology Projects, 2001-2005
- Private Sector Participation
- Approved Biotechnology Manufacturing Projects, 2001-2005 (RM Million)
- Ninth National Plan 2006-2010
- Biotechnology Development
- Building a Malaysian Brand
- Regulatory Framework
- Financial Infrastructure
- Human Capital Development
- R&D and Technology Acquisition
- Institutional Support and Allocation
- Development Expenditure and Allocation for Biotechnology, 2001-2010
(RM million)
- Ministry of Science & Technology/BIOTEK
- Malaysian Biotechnology Corporation (BiotechCorp)
- Malaysian Bio-industry Organisation
- Incubators
- Manufacturing & Research
- Actis Biologics
- Actis Biologics - Pipeline
- Alpha Biologics
- Autoimmune Sdn Bhd
- BioFact Life Sdn Bhd
- Bio Molecular Industries Sdn Bhd
- Bioven
- Biovic Sdn Bhd
- CCM Duopharma Biotech
- Inno Biologics
- InQpharm Asia
- KL Biotech Manufacturing Sdn Bhd
- StemLife Berhad
- Stempeutics Research Malaysia Sdn Bhd
- Synamatix
- Agreements
- Universiti Malaysia Sabah Biotechnology Research Institute
- Emory University School of Medicine
- 454 Life Sciences
- Malaysian Genomics Resources Centre
- Vivantis Technologies Sdn Bhd (lab services)
- SINGAPORE
- Biotechnology Market Overview
- Investment
- Investment Commitments in Biomedical Manufacturing
- Biopharmaceutical Market
- Singapore - Projected Biopharmaceutical Market 2008-2013 (US$ million)
- Pharmaceutical Market
- Summary of the Singapore Pharmaceutical Market, 2008
- Market Projections, 2008-2013
- Market Environment
- Government Biotechnology Initiatives
- Biomedical Sciences Initiative
- Singapore Economic Development Board
- A*STAR
- Biomedical Research Council (BMRC)
- Biopolis
- Bio*One Capital
- Bio*One Capital Investment Funds
- Singapore Bio-Innovations (SBI)
- PharmBio Growth Fund/Life Sciences Investment Fund (PGF/LSI)
- Biomedical Sciences Investment Fund (BMSIF)
- BMS INC (Innovate ‘N' Create)
- Manufacturing & Research - Multinational Investments
- Genentech
- GlaxoSmithKline
- Lonza
- Schering-Plough
- Manufacturing & Research - Domestic
- 1st BASE
- A-Bio Pharma
- Agreements
- Artisan Pharma
- GSK Biologicals
- AMRI Singapore
- Agreements
- Achaogen
- Cystic Fibrosis Foundation
- Financials
- CellResearchCorp
- Chakra Biotech Sdn Bhd
- Chakragati Mouse
- Novel Compounds
- Agreements
- Tikvah Therapeutics
- University at Buffalo
- ES Cell International
- Agreements
- Curis
- Ortec International
- Quark Biotech
- Experimental Therapeutics Centre
- i-DNA Biotechnology
- Innogene Kalbiotech
- Innogene Kalbio - Product Portfolio
- Innogene Kalbiotech - Biopharmaceutical R&D Portfolio
- LYNK Biotechnologies
- Maccine
- MerLion
- Agreements
- Astellas Pharma
- Banyu Pharmaceutical
- National Cancer Institute
- National Parks Board of Singapore
- Novartis Institute for Tropical Diseases
- Financials
- Moleac
- S*BIO
- Research & Development
- HDAC
- Kinase Programme
- Agreements
- Genome Institute of Singapore
- Karolinska Institutet
- SciGen
- Product Portfolio
- Pipeline Products
- Financials
- SciGen Revenues by Geographic Breakdown, 2007
- SingVax
- TAIWAN
- Biotechnology Market Overview
- Current Status of Biotechnology Development in Taiwan - 2005
- Biopharmaceutical Market
- Taiwan - Projected Biopharmaceutical Market 2008-2013 (US$ million)
- Pharmaceutical Market
- Summary of the Taiwanese Pharmaceutical Market in 2008
- Projected Pharmaceutical Market, 2008-2013
- Market Environment
- Government Biotechnology Initiatives
- Promotion Plan for the Biotechnology Industry
- Bio-Tech Island Project
- Biotech and New Pharmaceutical Development Statute
- Investment
- Research
- Development Center for Biotechnology
- Manufacturing & Research
- Abnova
- AbGenomics
- AbGenomics - R&D Pipeline
- ADImmune
- Empax Pharma
- Life Spring BioTech
- Mycenax Biotech
- Mycenax - Project Pipeline
- NatureWise Biotech & Medicals
- PhytoHealth
- ScinoPharm
- Synmosa Biopharma
- TaiGen Biotechnology
- Agreements
- P&G Pharmaceuticals
- Academia Sinica
- Chang Gung Memorial Hospital
- BioXell SpA
- Arena Pharmaceuticals
- R&D
- Financial Data
- TaiMed Biologics
- Taiwan Liposome
- TTY Biopharm
- R&D
- Agreements
- TaiGen Biotechnology
- Taiwan Liposome
- YM BioSciences
- THAILAND
- Biotechnology Market Overview
- Biopharmaceutical Market
- Thailand - Projected Biopharmaceutical Market 2008-2013 (US$ million)
- Pharmaceutical Market
- Summary of the Thai Pharmaceutical Market, 2008
- Market Projections, 2008-2013
- Market Environment
- Government Biotechnology Initiatives
- Manufacturing & Research
- Delphi Health Services
- Immunitor
- APPENDIX - BIBLIOGRAPHY
- APPENDIX - ACRONYMS
- APPENDIX - EXCHANGE RATES
|
 |
